Loading…
Aarti Drugs (AARTIDRUGS)₹499.75+11.08%Pharmaceuticals
At the end of the Jun 2026 quarter, Aarti Drugs' shareholders were: promoters 54.47%, FIIs 1.51%, DIIs 10.31%, public 33.71%. Promoter holding is down 0.60 percentage points from 55.07% a quarter earlier. FII holding is down 0.74 percentage points from 2.25% a year earlier. 2.48% of promoter shares were pledged. It had 1,43,437 shareholders.
As of · Company filings (shareholding pattern)
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 58.61% | 57.51% | 57.17% | 55.71% | 55.68% | 55.42% | 55.52% | 55.27% | 54.76% | 55.07% | 55.07% | 54.47% |
| FIIs | 2.32% | 2.09% | 2.55% | 2.94% | 2.49% | 2.27% | 2.24% | 2.25% | 2.67% | 2.14% | 1.56% | 1.51% |
| DIIs | 5.33% | 5.27% | 6.01% | 7.37% | 7.85% | 8.79% | 9.72% | 9.96% | 9.92% | 10.14% | 10.24% | 10.31% |
| Public | 33.74% | 35.13% | 34.27% | 33.98% | 33.98% | 33.52% | 32.52% | 32.52% | 32.65% | 32.65% | 33.13% | 33.71% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 2.48% |
| Number of shareholders | 1,67,400 | 1,70,367 | 1,57,504 | 1,50,177 | 1,90,229 | 1,75,958 | 1,69,714 | 1,60,216 | 1,52,210 | 1,48,322 | 1,44,906 | 1,43,437 |
| Holder | Category | Jun 2026 | Change (pp) |
|---|---|---|---|
| Prakash Moreshwar Patil | Promoter | 9.58% | 0.00 |
| DSP Small Cap Fund | DII | 7.95% | −0.08 |
| Harshit Manilal Savla | Promoter | 4.74% | −0.01 |
| Rashesh Chandrakant Gogri | Promoter | 4.68% | 0.00 |
| Priti Prakash Patil | Promoter | 4.44% | 0.00 |
| Seema Harshit Savla | Promoter | 3.81% | −0.01 |
| Gogri Finserv Pvt. Ltd. | Promoter | 3.77% | 0.00 |
| Hetal Gogri Gala | Promoter | 3.07% | 0.00 |
| Harit Pragji Shah | Public | 2.65% | 0.00 |
| Anushakti Enterprise Private Limited | Promoter | 2.61% | 0.00 |
| Alchemie Finserv Pvt. Ltd. | Promoter | 2.19% | 0.00 |
| ICICI Prudential Pharma Healthcare And Diaganostics (P.H.D) Fund | DII | 2.05% | +0.03 |
| Chandrakant Vallabhaji Gogri | Promoter | 1.86% | 0.00 |
| Jayshree Harit Shah | Public | 1.77% | 0.00 |
| Jaya Chandrakant Gogri | Promoter | 1.72% | 0.00 |
| Aashyav Business Trust (Alabhya Trusteeship Private Limited) | Promoter | 1.51% | 0.00 |
| Adhish P. Patil | Promoter | 1.26% | 0.00 |
| Bhoomi Harshit Savla | Promoter | 1.08% | 0.00 |
| Vishwa Harshit Savla | Promoter | 1.02% | 0.00 |
| Aashay Rashesh Gogri | Promoter | 0.97% | 0.00 |
| Mirik Rajendra Gogri | Promoter | 0.70% | 0.00 |
| Renil Rajendra Gogri | Promoter | 0.67% | 0.00 |
| Paridhi Business Trust (Saswat Trusteeship Private Limited) | Promoter | 0.64% | 0.00 |
| Tulip Family Trust (Gloire Trusteeship Services Private Limited | Promoter | 0.52% | −0.22 |
| Jigna Hiren Shah | Promoter | 0.50% | 0.00 |
Promoters held 54.47% of Aarti Drugs at the end of the Jun 2026 quarter, down 0.80 percentage points from 55.27% a year earlier.
In the Jun 2026 quarter, foreign institutional investors (FIIs) held 1.51% (down 0.05 percentage points from 1.56% a quarter earlier) and domestic institutions (DIIs) held 10.31% (up 0.07 percentage points from 10.24% a quarter earlier).
Yes. 2.48% of promoter shares were pledged at the end of the Jun 2026 quarter.
Aarti Drugs had 1,43,437 shareholders at the end of the Jun 2026 quarter, against 1,60,216 a year earlier.
DSP Small Cap Fund (DII) held 7.95% at the end of the Jun 2026 quarter, the largest named holding outside the promoter group.